Practical Perspectives on Clinical Controversies in MS
A Case-Based Approach
Music City Center, Nashville, Tennessee
Thursday, May 31, 2018 @ 4:30 pm

    Brief clinical vignettes introduce 3 patients with multiple sclerosis (MS) -- one with clinically isolated syndrome, another with highly active MS, and a third who is planning a pregnancy -- followed by expert faculty members' in-depth discussion of these cases. These scenarios highlight the need for highly effective therapy, which Dr Leist will discuss further in the final segment of the program.

    • Stephen Krieger, MD
      Associate Professor of Neurology; Director, Neurology Residency Program, Icahn School of Medicine at Mount Sinai, New York, New York
    • Anne H. Cross, MD
      Professor of Neurology, Manny and Rosalyn Rosenthal - Dr. John Trotter; MS Chair in Neuroimmunology, Washington University School of Medicine, Saint Louis, Missouri
    • Maria Houtchens, MD, MMS
      Assistant Professor of Neurology; Director, Women's Health Program, Partners MS Center, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts
    • Thomas P. Leist, MD, PhD
      Professor of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania
    Program Thursday, May 31, 2018
    • 4:30 PM
    • Dinner and Registration
    • 5:00 PM
    • Welcome, Instructions, and Introductions
      Stephen Krieger, MD
    • 5:05 PM
    • Treatment Decisions in Clinically Isolated Syndrome: Impact of the 2017 Updated McDonald Criteria
      Stephen Krieger, MD
    • 5:25 PM
    • Management Considerations for Highly Active RRMS
      Anne H. Cross, MD
    • 5:45 PM
    • Pregnancy in MS: Strategies for Care
      Maria Houtchens, MD, MMS
    • 6:05 PM
    • Review of High-Efficacy Therapies in Development for MS
      Thomas P. Leist, MD, PhD
    • 6:20 PM
    • Questions & Answers
    Meet Your MS Patients
    Target Audience
    Goal Statement
    Learning Objectives
    • Have increased knowledge regarding the
      • Clinical data for new and emerging disease-modifying therapies in MS
    • Have greater competence related to
      • Development of an individualized treatment plan for a patient with MS who is interested in becoming pregnant
      • Selection of an appropriate therapy for the management of patients with highly active relapsing-remitting MS (RRMS)
    Accreditation Statement
    Credits Available
    • 1.50
    • For Physicians
    Nashville, Tennessee
    Music City Center
    Ballroom A
    201 Fifth Avenue South
    Supported by an independent educational grant from
    EMD Serono